Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodJacques J. M. van Dongen, Claus R. Bartram, Willem A. Kamps et al.|The Lancet|1998Cited by 964
Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004)Anna Berg, Willem A. Kamps, Henk van den Berg et al.|The Lancet Oncology|2009Cited by 250
Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the “BFM family” cooperative groupAnna Berg, Elisabeth R. van Wering, Claus R. Bartram et al.|Medical and Pediatric Oncology|1992Cited by 109
Prognostic Significance of Blasts in the Cerebrospinal Fluid Without Pleiocytosis or a Traumatic Lumbar Puncture in Children With Acute Lymphoblastic Leukemia: Experience of the Dutch Childhood Oncology GroupD. Maroeska W. M. te Loo, Siebold S.N. de Graaf, Willem A. Kamps et al.|Journal of Clinical Oncology|2006Cited by 105
Malignant lymphomas in children in the Netherlands in the period 1973‐1985: Incidence in relation to leukemia: A report from the dutch childhood leukemia study groupJ.W.W. Coebergh, Elisabeth R. van Wering, Anna Berg et al.|Medical and Pediatric Oncology|1991Cited by 14